Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Diabetes Reviews
  4. Volume 21, Issue 6
  5. Article
Volume 21, Issue 6
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

Background

Diabetes technology in the form of digital health or medical devices holds a promise for improving the quality of life and glycemic outcomes. A comprehensive insight into diabetes technology and its impact in Saudi Arabia and the MENA region may improve type 1 diabetes mellitus (T1DM) management.

Objective

This study aimed to assess the impact of different DM-specific technologies: Insulin pump therapy, continuous glucose monitoring (CGM), and automated insulin delivery system in terms of glycemic control and QoL among T1DM patients in Saudi Arabia and the MENA region.

Methods

A systematic literature search was performed in PubMed and Scopus from 2005 until August 2023. The search was based on the PICO strategy, focusing on T1DM patients, diabetes technology, and QoL. The inclusion criteria were studies illustrating the effect of diabetes technologies on glycemic control or quality of life or both among T1DM patients. Systematic reviews, books, letters, or studies, including type 2 diabetes mellitus, were excluded.

Results

From 101 articles, eighteen studies were duplicated, and thirty-three studies were excluded after reading the title and abstract. Of the 50 articles analyzed, twenty-five articles did not meet the inclusion criteria. Therefore, 25 articles involving a total of 3088 participants were enrolled in the study. It was shown that a continuous glucose monitoring system and continuous subcutaneous insulin infusion improved the glycemic control and the QoL of T1DM patients.

Conclusion

There was a positive impact of insulin pumps, continuous glucose monitoring (CGM) systems, and telemedicine in achieving optimal glucose control and better QoL. Further studies are recommended to clarify the significant role of advanced diabetes technologies.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998295755240416060913
2024-04-26
2025-05-10

  • From This Site

    /content/journals/cdr/10.2174/0115733998295755240416060913
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AlanaziF.K. AlotaibiJ.S. PaliadelisP. AlqarawiN. AlsharariA. AlbagawiB. Knowledge and awareness of diabetes mellitus and its risk factors in Saudi Arabia.Saudi Med. J.2018391098198910.15537/smj.2018.10.2293830284579
     [Google Scholar]
  2. Diagnosis and Classification of Diabetes MellitusDiagnosis and Classification of Diabetes Mellitus.Diabetes Care201437Suppl. 1S81S90Available from: https://diabetesjournals.org/care/article/37/Supplement_1/S81/37753/Diagnosis-and-Classification-of-Diabetes-Mellitus 10.2337/dc14‑S08124357215
     [Google Scholar]
  3. LucierJ. WeinstockR.S. Type 1 DiabetesIn: StatPearlsTreasure Island (FL)StatPearls Publishing2023
     [Google Scholar]
  4. RobertA.A. Al-DawishA. MujammamiM. DawishM.A.A. Type 1 diabetes mellitus in Saudi Arabia: A soaring epidemic.Int. J. Pediatr.201820181910.1155/2018/940837029853923
     [Google Scholar]
  5. LeslieR.D. Evans-MolinaC. Freund-BrownJ. BuzzettiR. DabeleaD. GillespieK.M. GolandR. JonesA.G. KacherM. PhillipsL.S. RolandssonO. WardianJ.L. DunneJ.L. Adult-onset type 1 Diabetes: Current understanding and challenges.Diabetes Care202144112449245610.2337/dc21‑077034670785
     [Google Scholar]
  6. MobasseriM. ShirmohammadiM. AmiriT. VahedN. Hosseini FardH. GhojazadehM. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis.Health Promot Perspect20201029811510.34172/hpp.2020.18
     [Google Scholar]
  7. EsmaeiliS. Saeedi MoghaddamS. NamaziN. BandarianF. EsfahaniZ. PeimaniM. ShahinS. Nasli-EsfahaniE. AkbarzadehI. GhanbariA. RezaeiN. RezaeiN. LarijaniB. FarzadfarF. Burden of type 1 diabetes mellitus in the North Africa and Middle East Region, 1990–2019; findings from the global burden of disease study.Diabetes Res. Clin. Pract.202218810991210.1016/j.diabres.2022.10991235537522
     [Google Scholar]
  8. PattersonC.C. KarurangaS. SalpeaP. SaeediP. DahlquistG. SolteszG. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.Diabetes Res Clin Pract201915710784210.1016/j.diabres.2019.10784231518658
     [Google Scholar]
  9. American Diabetes Association Professional Practice Committee7. Diabetes Technology: Standards of Medical Care in Diabetes—2022.Diabetes Care202245Suppl. 1S97S11210.2337/dc22‑S00734964871
     [Google Scholar]
  10. FlemingG.A. PetrieJ.R. BergenstalR.M. HollR.W. PetersA.L. HeinemannL. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.Diabetes Care202043125026010.2337/dci19‑006231806649
     [Google Scholar]
  11. American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022Diabetes Care202043Suppl. 1S77S8831862750
     [Google Scholar]
  12. PrahaladP. TanenbaumM. HoodK. MaahsD.M. Diabetes technology: improving care, improving patient‐reported outcomes and preventing complications in young people with Type 1 diabetes.Diabet. Med.201835441942910.1111/dme.1358829356074
     [Google Scholar]
  13. Abdullah Al HayekA. Alwin RobertA. Alzahrani WM. Al DawishM.A. Assessment of patient-reported satisfaction and metabolic outcomes following initiation of the second generation of Flash Glucose Monitoring in patients with type 1 diabetes.Curr. Diabetes Rev.2023204Available from: https://www.eurekaselect.com/219628/article
    [Google Scholar]
  14. BabikerA. AlammariN. AljuraisiA. AlharbiR. AlqarniH. MasuadiE. AlfaraidiH. The Effectiveness of insulin pump therapy versus multiple daily injections in children with type 1 diabetes mellitus in a Specialized Center in Riyadh.Clin. Med. Insights Endocrinol. Diabetes2022151179551422112849510.1177/1179551422112849536313241
     [Google Scholar]
  15. Al HayekA.A. RobertA.A. Al DawishM.A. Efficacy of i-Port Advance system on patients satisfaction and glycemic control among patients with type 1 diabetes in Saudi Arabia.Diabetes Metab Syndr202115374775110.1016/j.dsx.2021.03.02833823329
     [Google Scholar]
  16. GhafoorE. MasoodS. BelkhadirJ. SultanM. SandidM. BaqaiS. Availability and accessibility of diabetes-related technologies in IDF-MENA Region.J Diabetol20221358110.4103/jod.jod_117_22
     [Google Scholar]
  17. PageM.J. McKenzieJ.E. BossuytP.M. BoutronI. HoffmannT.C. MulrowC.D. ShamseerL. TetzlaffJ.M. AklE.A. BrennanS.E. ChouR. GlanvilleJ. GrimshawJ.M. HróbjartssonA. LaluM.M. LiT. LoderE.W. Mayo-WilsonE. McDonaldS. McGuinnessL.A. StewartL.A. ThomasJ. TriccoA.C. WelchV.A. WhitingP. MoherD. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ2021372n7110.1136/bmj.n7133782057
     [Google Scholar]
  18. NIH Study quality assessment toolAvailable from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools#:~:text=In
  19. SheaB.J. ReevesB.C. WellsG. ThukuM. HamelC. MoranJ. MoherD. TugwellP. WelchV. KristjanssonE. HenryD.A. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.BMJ2017358j400810.1136/bmj.j400828935701
     [Google Scholar]
  20. AlmogbelE. Impact of insulin pump therapy on glycemic control among adult Saudi type-1 diabetic patients. An interview-based case-control study.J. Family Med. Prim. Care2020921013101910.4103/jfmpc.jfmpc_869_1932318460
     [Google Scholar]
  21. Al HayekA.A. Al DawishM.A. the potential impact of the freestyle libre flash glucose monitoring system on mental well-being and treatment satisfaction in patients with type 1 diabetes: A prospective study.Diabetes Ther20191041239124810.1007/s13300‑019‑0616‑431066017
     [Google Scholar]
  22. Al-MusaH.M. AftabR. Effectiveness of continuous glucose monitoring for managing type-1 diabetic patients and barrier to its use: A quasi interventional trial.J Krishna Inst Med Sci.2018726879
     [Google Scholar]
  23. AlamoudiR. AlsubaieeM. AlqarniA. SalehY. AljaserS. SalamA. EledrisiM. Comparison of insulin pump therapy and multiple daily injections insulin regimen in patients with type 1 diabetes during ramadan fasting.Diabetes Technol. Ther.201719634935410.1089/dia.2016.041828296467
     [Google Scholar]
  24. Al-AghaA.E. KafiS.E. AldeenA.M.Z. KhadwardiR.H. Flash glucose monitoring system may benefit children and adolescents with type 1 diabetes during fasting at Ramadan.Saudi Med. J.201738436637110.15537/smj.2017.4.1875028397942
     [Google Scholar]
  25. Al HayekA.A. RobertA.A. Al DawishM. AhmedR.A. Al SabaanF.S. The evolving role of short-term professional continuous glucose monitoring on glycemic control and hypoglycemia among saudi patients with type 1 diabetes: A prospective study.Diabetes Ther.20156332933710.1007/s13300‑015‑0120‑426142891
     [Google Scholar]
  26. Al HayekA.A. RobertA.A. Al DawishM.A. BrahamR.B. GoudehH.S. Al SabaanF.S. Efficacy of insulin pump therapy on diabetes treatment satisfaction and glycemic control among patients with type 1 diabetes mellitus in Saudi Arabia: A prospective study.Diabetes Ther2015622273610.1007/s13300‑015‑0107‑125924588
     [Google Scholar]
  27. Bin-AbbasBS Bin-AbbasBS Insulin pump therapy during Ramadan fasting.Curr Pediatr Res2007111 & 23334
     [Google Scholar]
  28. Bin-AbbasB.S. Al FaresA. SakatiN.A. Al AshwalA.A. Comparison of insulin pump and multiple daily injection regimens in type 1 diabetic patients.Curr Pediatr Res.2006103739
     [Google Scholar]
  29. Bin-AbbasB.S. Al-FaresA. SakatiN.A. AbdullahA. Al-Ashwal Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children: two-year follow-up.Curr Pediatr Res.2006101–23335
     [Google Scholar]
  30. Bin-AbbasB.S. SakatiN.A. RaefH. Al-AshwalA.A. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapy.Saudi Med. J.200526691892215983674
     [Google Scholar]
  31. AlharbiM.Y. AlbunyanA. Al NahariA. Al AzmiF. AlenaziB. Al HarbiT. Al MalkiM. Al AhmadiH. Measuring the Impact of Flash Glucose Monitoring in a Pediatric Population in Saudi Arabia: A Retrospective Cohort Study.Diabetes Ther.20221361139114610.1007/s13300‑022‑01224‑035441933
     [Google Scholar]
  32. AldibbiatA. AlqashamiA. HussainS. Use of automated insulin delivery systems in people with type 1 diabetes fasting during Ramadan: An observational studyJ Diabetes Investig202213464765110.1111/jdi.1372034826214
     [Google Scholar]
  33. AlharthiS.K. AlyusufE.Y. AlguwaihesA.M. AlfaddaA. Al-SofianiM.E. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.Diabetes Res Clin Pract202117310868210.1016/j.diabres.2021.10868233539868
     [Google Scholar]
  34. Al HayekA.A. RobertA.A. Al DawishM.A. Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump.Diabetes Metab Syndr202115510226510.1016/j.dsx.2021.10226534488057
     [Google Scholar]
  35. MohamedI. TalaatI.M. AlghamdiH.A. AllamG. Role of free style Libre-Flash Glucose Monitoring: Glycemic control of Type-1 Diabetes.Pak. J. Med. Sci.20213771883188910.12669/pjms.37.7.411434912412
     [Google Scholar]
  36. Al HayekA.A. Al DawishM.A. assessing diabetes distress and sleep quality in young adults with type 1 diabetes using freestyle Libre: A prospective cohort study.Diabetes Ther20201171551156210.1007/s13300‑020‑00849‑332495021
     [Google Scholar]
  37. Al ShaikhA. Al ZahraniA.M. QariY.H. AbuAlnasrA.A. AlhawsawiW.K. AlshehriK.A. Quality of life in children with diabetes treated with insulin pump compared with multiple daily injections in Tertiary Care Center.Clin Med Insights Endocrinol Diabetes202013117955142095907710.1177/117955142095907733088186
     [Google Scholar]
  38. ElbarbaryN.S. IsmailE.A.R. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial.Diabetes Res. Clin. Pract.202219111004510.1016/j.diabres.2022.11004535987309
     [Google Scholar]
  39. AlmazroueiR. SharmaC. AfandiB. AldahmaniK.M. AburawiE.H. BeshyahS.A. Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes.PLoS One2022179e026454510.1371/journal.pone.026454536136973
     [Google Scholar]
  40. MesbahN.I. TahaN.A. RahmeZ.N. SukkarF.F. OmarD.M. Experiences of adults using continuous subcutaneous insulin infusion: A qualitative study.Med Princ Pract202029325526110.1159/00050370531557759
     [Google Scholar]
  41. MerhebM. ChaibanJ. SaltiI. SammakR. ChoucairM. NasrallahM. Insulin pump therapy in type 1 diabetic patients: experience at the American University of Beirut Medical Center.Dubai Diabetes Endocrinol J.20081625761
     [Google Scholar]
  42. BattelinoT. CongetI. OlsenB. Schütz-FuhrmannI. HommelE. HoogmaR. SchierlohU. SulliN. BolinderJ. SWITCH Study Group The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.Diabetologia201255123155316210.1007/s00125‑012‑2708‑922965294
     [Google Scholar]
  43. ChiangJ.L. MaahsD.M. GarveyK.C. HoodK.K. LaffelL.M. WeinzimerS.A. WolfsdorfJ.I. SchatzD. Type 1 Diabetes in children and adolescents: A position statement by the American Diabetes Association.Diabetes Care20184192026204410.2337/dci18‑002330093549
     [Google Scholar]
  44. SherrJ.L. TauschmannM. BattelinoT. de BockM. ForlenzaG. RomanR. HoodK.K. MaahsD.M. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies.Pediatr. Diabetes201819Suppl. 2730232510.1111/pedi.1273130039513
     [Google Scholar]
  45. DeSalvoD.J. MillerK.M. HermannJ.M. MaahsD.M. HoferS.E. ClementsM.A. LilienthalE. SherrJ.L. TauschmannM. HollR.W. T1D Exchange and DPV Registries Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.Pediatr. Diabetes20181971271127510.1111/pedi.1271129923262
     [Google Scholar]
  46. LadoJ.J. LipmanT.H. Racial and ethnic disparities in the incidence, treatment, and outcomes of youth with type 1 diabetes.Endocrinol. Metab. Clin. North Am.201645245346127241975
     [Google Scholar]
  47. WilliS.M. MillerK.M. DiMeglioL.A. KlingensmithG.J. SimmonsJ.H. TamborlaneW.V. NadeauK.J. KittelsrudJ.M. HuckfeldtP. BeckR.W. LipmanT.H. T1D Exchange Clinic Network Racial-ethnic disparities in management and outcomes among children with type 1 diabetes.Pediatrics2015135342443425687140
     [Google Scholar]
  48. SherrJ.L. HermannJ.M. CampbellF. FosterN.C. HoferS.E. AllgroveJ. MaahsD.M. KapellenT.M. HolmanN. TamborlaneW.V. HollR.W. BeckR.W. WarnerJ.T. T1D Exchange Clinic Network, the DPV Initiative, and the National Paediatric Diabetes Audit and the Royal College of Paediatrics and Child Health registries Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries.Diabetologia2016591879126546085
     [Google Scholar]
  49. BlackmanS.M. RaghinaruD. AdiS. SimmonsJ.H. Ebner-LyonL. ChaseH.P. TamborlaneW.V. SchatzD.A. BlockJ.M. LittonJ.C. RamanV. FosterN.C. KollmanC.R. DuBoseS.N. MillerK.M. BeckR.W. DiMeglioL.A. Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy.Pediatr. Diabetes201415856457210.1111/pedi.1212124494980
     [Google Scholar]
  50. WongJ.C. DolanL.M. YangT.T. HoodK.K. Insulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two years.Pediatr. Diabetes201516859259910.1111/pedi.1222125387433
     [Google Scholar]
  51. LawsonM.L. BradleyB. McAsseyK. ClarsonC. KirschS.E. MahmudF.H. CurtisJ.R. RichardsonC. CourtneyJ. CooperT. DownieC.J. RajamannarG. BarrowmanN. CGM TIME Trial Study Group JDRF Canadian Clinical Trial Network CCTN1101 The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.BMC Pediatr.201414118310.1186/1471‑2431‑14‑18325034216
     [Google Scholar]
  52. VigerskyR.A. The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus.J. Diabetes Sci. Technol.20159232033010.1177/193229681456566125555391
     [Google Scholar]
  53. KlonoffD.C. BuckinghamB. ChristiansenJ.S. MontoriV.M. TamborlaneW.V. VigerskyR.A. WolpertH. Endocrine Society Continuous glucose monitoring: An endocrine society clinical practice guideline.J. Clin. Endocrinol. Metab.201196102968297910.1210/jc.2010‑275621976745
     [Google Scholar]
  54. ShahR. ShahV.N. PatelM. MaahsD.M. Insulin delivery methods: Past, present and future.Int. J. Pharm. Investig.2016611910.4103/2230‑973X.17645627014614
     [Google Scholar]
  55. HassaneinM. AfandiB. Yakoob AhmedaniM. Mohammad AlamoudiR. AlawadiF. BajajH.S. BasitA. BennakhiA. El SayedA.A. HamdyO. HanifW. JabbarA. KleinebreilL. LessanN. ShaltoutI. Mohamad Wan BebakarW. AbdelgadirE. AbdoS. Al OzairiE. Al SalehY. AlaroujM. AliT. Ali AlmadaniA. Helmy Assaad-KhalilS. BashierA.M.K. Arifi BeshyahS. BuyukbeseM.A. Ahmad ChowdhuryT. Norou DiopS. Samir ElbarbaryN. ElhaddT.A. ElianaF. Ezzat FarisM. HafidhK. HusseinZ. IraqiH. KaplanW. KhanT.S. KhuntiK. MaherS. MalekR. MalikR.A. MohamedM. Sayed Kamel MohamedM. Ahmed MohamedN. PathanS. RashidF. SahayR.K. Taha SalihB. SandidM.A. ShaikhS. SlimI. TayebK. Mohd YusofB.N. Binte ZainudinS. Diabetes and Ramadan: Practical guidelines 2021.Diabetes Res. Clin. Pract.202218510918510.1016/j.diabres.2021.10918535016991
     [Google Scholar]
  56. KaplanW. AfandiB. Blood glucose fluctuation during Ramadan fasting in adolescents with type 1 diabetes: findings of continuous glucose monitoring.Diabetes Care20153810e162e16310.2337/dc15‑110826294662
     [Google Scholar]
  57. Al-OzairiE El SamadA Al KandariJ AldibbiatAM Intermittent fasting could be safely achieved in people with type 1 diabetes undergoing structured education and advanced glucose monitoring.Front Endocrinol (Lausanne)20191084910.3389/fendo.2019.0084931866948
     [Google Scholar]
/content/journals/cdr/10.2174/0115733998295755240416060913
Loading
Technology for the Management of Type 1 Diabetes Mellitus in Saudi Arabia and MENA Region: A Systematic Review
Curr. Diabetes Rev. 21, E260424229416 (2025); https://doi.org/10.2174/0115733998295755240416060913
/content/journals/cdr/10.2174/0115733998295755240416060913
/content/journals/cdr/10.2174/0115733998295755240416060913
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article. Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): continuous glucose monitoring system; diabetes mellitus; glucose monitoring; insulin; insulin pumps; Type 1 diabetes

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test